Child Care Showdown: Nannies vs. Family Care vs. Day Care
Still Checking Off That Gift List? Shop and Save on Dec. 18
Marriage, Dowers and an Argument Against Diamond Rings
Can Amazon and Netflix Bounce Back in 2015?
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.